FDA OKs Trial of Investigational Drug for Advanced Solid Tumors

This summer, a trial will kick off studying ISM3091 in patients with advanced solid tumors.

Related Keywords

Feng Ren ,Fujian ,China ,United States ,Sujata Rao ,Drug Administration ,Insilco Medicine ,Insilico Medicine ,Clinical Trial Corner ,